Pediatric follicular lymphoma in Japan

Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group

Research output: Contribution to journalArticle

Abstract

Follicular lymphoma (FL) is quite rare in children. There have been only two major reports on pediatric FL. The present retrospective study on pediatric FL in Japan, including FL with diffuse large B cell lymphoma (DLBCL), analyzed data from 1991 to 2014. Twenty-two patients with pediatric FL were analyzed. Sixteen patients were boys and six were girls. Median age of onset was 9 years (range 4–17 years). In 11 patients, DLBCL co-existed with FL. The initial lesions involved cervical lesions in 16 patients, and the abdomen in six. With regard to stage of disease at diagnosis, 17 patients were at stage I or II, four were at stage III, and one was at stage IV. Chemotherapy was administered in 18 patients, and only resection was performed in four patients. Mature B lymphoma regimens were selected for 17 patients who received chemotherapy. Although two patients relapsed, all patients are currently alive and disease free. The median follow-up period was 54.5 months (range 6–126 months). Patients having FL with DLBCL were younger compared with those having FL, and this disease was more frequently observed in female patients. Our data revealed that FL in Japanese children is a tumor with good prognosis, as in reports from the United States and Europe.

Original languageEnglish
Pages (from-to)849-853
Number of pages5
JournalInternational journal of hematology
Volume105
Issue number6
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Follicular Lymphoma
Japan
Pediatrics
Lymphoma, Large B-Cell, Diffuse
Drug Therapy
Age of Onset
Abdomen
Lymphoma
Retrospective Studies

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group (2017). Pediatric follicular lymphoma in Japan. International journal of hematology, 105(6), 849-853. https://doi.org/10.1007/s12185-017-2209-1

Pediatric follicular lymphoma in Japan. / Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group.

In: International journal of hematology, Vol. 105, No. 6, 01.06.2017, p. 849-853.

Research output: Contribution to journalArticle

Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group 2017, 'Pediatric follicular lymphoma in Japan', International journal of hematology, vol. 105, no. 6, pp. 849-853. https://doi.org/10.1007/s12185-017-2209-1
Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric follicular lymphoma in Japan. International journal of hematology. 2017 Jun 1;105(6):849-853. https://doi.org/10.1007/s12185-017-2209-1
Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group. / Pediatric follicular lymphoma in Japan. In: International journal of hematology. 2017 ; Vol. 105, No. 6. pp. 849-853.
@article{26b8d88842314f03a811f06a5cef928c,
title = "Pediatric follicular lymphoma in Japan",
abstract = "Follicular lymphoma (FL) is quite rare in children. There have been only two major reports on pediatric FL. The present retrospective study on pediatric FL in Japan, including FL with diffuse large B cell lymphoma (DLBCL), analyzed data from 1991 to 2014. Twenty-two patients with pediatric FL were analyzed. Sixteen patients were boys and six were girls. Median age of onset was 9 years (range 4–17 years). In 11 patients, DLBCL co-existed with FL. The initial lesions involved cervical lesions in 16 patients, and the abdomen in six. With regard to stage of disease at diagnosis, 17 patients were at stage I or II, four were at stage III, and one was at stage IV. Chemotherapy was administered in 18 patients, and only resection was performed in four patients. Mature B lymphoma regimens were selected for 17 patients who received chemotherapy. Although two patients relapsed, all patients are currently alive and disease free. The median follow-up period was 54.5 months (range 6–126 months). Patients having FL with DLBCL were younger compared with those having FL, and this disease was more frequently observed in female patients. Our data revealed that FL in Japanese children is a tumor with good prognosis, as in reports from the United States and Europe.",
author = "{Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group} and Ryoji Kobayashi and Fumiko Tanaka and Atsuko Nakazawa and Ueyama, {Jun ichi} and Shosuke Sunami and Tetsuo Mitsui and Yuhki Koga and Takeshi Mori and Tomoo Osumi and Reiji Fukano and Kentaro Ohki and Masahiro Sekimizu and Naoto Fujita and Michi Kamei and Tetsuya Mori",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s12185-017-2209-1",
language = "English",
volume = "105",
pages = "849--853",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Pediatric follicular lymphoma in Japan

AU - Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group

AU - Kobayashi, Ryoji

AU - Tanaka, Fumiko

AU - Nakazawa, Atsuko

AU - Ueyama, Jun ichi

AU - Sunami, Shosuke

AU - Mitsui, Tetsuo

AU - Koga, Yuhki

AU - Mori, Takeshi

AU - Osumi, Tomoo

AU - Fukano, Reiji

AU - Ohki, Kentaro

AU - Sekimizu, Masahiro

AU - Fujita, Naoto

AU - Kamei, Michi

AU - Mori, Tetsuya

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Follicular lymphoma (FL) is quite rare in children. There have been only two major reports on pediatric FL. The present retrospective study on pediatric FL in Japan, including FL with diffuse large B cell lymphoma (DLBCL), analyzed data from 1991 to 2014. Twenty-two patients with pediatric FL were analyzed. Sixteen patients were boys and six were girls. Median age of onset was 9 years (range 4–17 years). In 11 patients, DLBCL co-existed with FL. The initial lesions involved cervical lesions in 16 patients, and the abdomen in six. With regard to stage of disease at diagnosis, 17 patients were at stage I or II, four were at stage III, and one was at stage IV. Chemotherapy was administered in 18 patients, and only resection was performed in four patients. Mature B lymphoma regimens were selected for 17 patients who received chemotherapy. Although two patients relapsed, all patients are currently alive and disease free. The median follow-up period was 54.5 months (range 6–126 months). Patients having FL with DLBCL were younger compared with those having FL, and this disease was more frequently observed in female patients. Our data revealed that FL in Japanese children is a tumor with good prognosis, as in reports from the United States and Europe.

AB - Follicular lymphoma (FL) is quite rare in children. There have been only two major reports on pediatric FL. The present retrospective study on pediatric FL in Japan, including FL with diffuse large B cell lymphoma (DLBCL), analyzed data from 1991 to 2014. Twenty-two patients with pediatric FL were analyzed. Sixteen patients were boys and six were girls. Median age of onset was 9 years (range 4–17 years). In 11 patients, DLBCL co-existed with FL. The initial lesions involved cervical lesions in 16 patients, and the abdomen in six. With regard to stage of disease at diagnosis, 17 patients were at stage I or II, four were at stage III, and one was at stage IV. Chemotherapy was administered in 18 patients, and only resection was performed in four patients. Mature B lymphoma regimens were selected for 17 patients who received chemotherapy. Although two patients relapsed, all patients are currently alive and disease free. The median follow-up period was 54.5 months (range 6–126 months). Patients having FL with DLBCL were younger compared with those having FL, and this disease was more frequently observed in female patients. Our data revealed that FL in Japanese children is a tumor with good prognosis, as in reports from the United States and Europe.

UR - http://www.scopus.com/inward/record.url?scp=85014559817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014559817&partnerID=8YFLogxK

U2 - 10.1007/s12185-017-2209-1

DO - 10.1007/s12185-017-2209-1

M3 - Article

VL - 105

SP - 849

EP - 853

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 6

ER -